Form 8-K Momentus Inc. For: Aug 21
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (date of earliest event reported)
(Exact name of registrant as specified in its charter)
| (State or other jurisdiction of incorporation or organization) | (Commission File Number) | (I.R.S. Employer Identification No.) | |||||||||
| (Address of Principal Executive Offices) | (Zip Code) | ||||||||||
(650 ) 564-7820
Registrant’s telephone number, including area code
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |||||
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |||||
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |||||
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | |||||
Securities registered pursuant to Section 12(g) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 1.02 Termination of a Material Definitive Agreement.
On September 25, 2025, Momentus Inc. (the “Company”) entered into an Equity Purchase Agreement with Yield Point NY LLC (the “Investor”), which was amended by a First Amendment to Equity Purchase Agreement, dated as of December 23, 2025 (as so amended, the “Equity Purchase Agreement”). The Equity Purchase Agreement provided the Company the right, but not the obligation, to direct the Investor to purchase up to $50,000,000 in shares of the Company’s Class A common stock from time to time, upon satisfaction of the terms and conditions set forth therein. Copies of the Equity Purchase Agreement and the First Amendment were filed as Exhibit 10.4 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission (the “SEC”) on September 29, 2025, and as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the SEC on December 29, 2025, respectively, and are incorporated herein by reference.
On August 21, 2026, the Company delivered written notice to the Investor pursuant to Section 10.6 of the Equity Purchase Agreement electing to terminate the Equity Purchase Agreement. Section 10.6 permits the Company, at any time following the effectiveness of the resale registration statement contemplated by the Equity Purchase Agreement, to terminate the Equity Purchase Agreement for any reason or for no reason. The Equity Purchase Agreement terminated effective as of August 21, 2026.
The Company has not utilized the Equity Purchase Agreement. The Company terminated the Equity Purchase Agreement because it does not intend to use the facility in the future.
The Company did not incur any early termination penalties in connection with the termination of the Equity Purchase Agreement.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
Exhibit Number | Exhibit Description | |||||||
104 | Cover Page Interactive Data File (embedded within the Inline XBRL document). | |||||||
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| By: | /s/ Lon Ensler | |||||||||||||
| Name: | Lon Ensler | |||||||||||||
| Dated: | August 25, 2026 | Title: | Chief Financial Officer | |||||||||||
ATTACHMENTS / EXHIBITS
XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Momentus terminates $50M equity purchase agreement with Yield Point NY
- PetSuper to Showcase Its Evolution Toward AI-Powered Pet Health Management at IFA 2026
- Levicept Announces Attendance at Cantor and Jefferies Global Healthcare Conferences
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share